Home

Revision Baka bön kappa antagonists on prolactin levels Ampere han bojkotta

Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting,  Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence  | Neuropsychopharmacology
Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence | Neuropsychopharmacology

Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as  a candidate therapeutic for alcohol use disorders | Neuropsychopharmacology
Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders | Neuropsychopharmacology

Kappa Opioid Receptor Antagonists as Potential Therapeutics for Mood and  Substance Use Disorders | SpringerLink
Kappa Opioid Receptor Antagonists as Potential Therapeutics for Mood and Substance Use Disorders | SpringerLink

a) Mean ( 7 SEM) level of serum prolactin at each time point from 0 to... |  Download Scientific Diagram
a) Mean ( 7 SEM) level of serum prolactin at each time point from 0 to... | Download Scientific Diagram

Alleviation of Cocaine Withdrawal and Pertinent Interactions between  Salvinorin-Based Antagonists and Kappa Opioid Receptor | ACS Chemical  Neuroscience
Alleviation of Cocaine Withdrawal and Pertinent Interactions between Salvinorin-Based Antagonists and Kappa Opioid Receptor | ACS Chemical Neuroscience

Dynorphin A1–13 Causes Elevation of Serum Levels of Prolactin Through an  Opioid Receptor Mechanism in Humans: Gender Differences and Implications  for Modulation of Dopaminergic Tone in the Treatment of Addictions | Journal
Dynorphin A1–13 Causes Elevation of Serum Levels of Prolactin Through an Opioid Receptor Mechanism in Humans: Gender Differences and Implications for Modulation of Dopaminergic Tone in the Treatment of Addictions | Journal

A systematic review on the kappa opioid receptor and its ligands: New  directions for the treatment of pain, anxiety, depression, and drug abuse -  ScienceDirect
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect

Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting,  Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence  | Neuropsychopharmacology
Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence | Neuropsychopharmacology

Antagonists of the kappa opioid receptor. | Semantic Scholar
Antagonists of the kappa opioid receptor. | Semantic Scholar

Opioid Receptor Subtypes Involved in the Regulation of Prolactin Secretion  During Pregnancy and Lactation - Andrews - 2003 - Journal of  Neuroendocrinology - Wiley Online Library
Opioid Receptor Subtypes Involved in the Regulation of Prolactin Secretion During Pregnancy and Lactation - Andrews - 2003 - Journal of Neuroendocrinology - Wiley Online Library

Frontiers | Opioid Receptor-Mediated Regulation of Neurotransmission in the  Brain
Frontiers | Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain

Molecules | Free Full-Text | The Kappa Opioid Receptor Agonist 16-Bromo  Salvinorin A Has Anti-Cocaine Effects without Significant Effects on  Locomotion, Food Reward, Learning and Memory, or Anxiety and  Depressive-like Behaviors
Molecules | Free Full-Text | The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors

Alleviation of Cocaine Withdrawal and Pertinent Interactions between  Salvinorin-Based Antagonists and Kappa Opioid Receptor | ACS Chemical  Neuroscience
Alleviation of Cocaine Withdrawal and Pertinent Interactions between Salvinorin-Based Antagonists and Kappa Opioid Receptor | ACS Chemical Neuroscience

Opioid Receptor Subtypes Involved in the Regulation of Prolactin Secretion  During Pregnancy and Lactation - Andrews - 2003 - Journal of  Neuroendocrinology - Wiley Online Library
Opioid Receptor Subtypes Involved in the Regulation of Prolactin Secretion During Pregnancy and Lactation - Andrews - 2003 - Journal of Neuroendocrinology - Wiley Online Library

Nalmefene Induced Elevation in Serum Prolactin in Normal Human Volunteers:  Partial Kappa Opioid Agonist Activity? | Neuropsychopharmacology
Nalmefene Induced Elevation in Serum Prolactin in Normal Human Volunteers: Partial Kappa Opioid Agonist Activity? | Neuropsychopharmacology

Summary of select antipsychotic drugs on prolactin levels | Download Table
Summary of select antipsychotic drugs on prolactin levels | Download Table

Opioid Receptor Subtypes Involved in the Regulation of Prolactin Secretion  During Pregnancy and Lactation - Andrews - 2003 - Journal of  Neuroendocrinology - Wiley Online Library
Opioid Receptor Subtypes Involved in the Regulation of Prolactin Secretion During Pregnancy and Lactation - Andrews - 2003 - Journal of Neuroendocrinology - Wiley Online Library

WO2018170492A1 - Kappa opioid receptor antagonists and products and methods  related thereto - Google Patents
WO2018170492A1 - Kappa opioid receptor antagonists and products and methods related thereto - Google Patents

Opioid Receptor Subtypes Involved in the Regulation of Prolactin Secretion  During Pregnancy and Lactation - Andrews - 2003 - Journal of  Neuroendocrinology - Wiley Online Library
Opioid Receptor Subtypes Involved in the Regulation of Prolactin Secretion During Pregnancy and Lactation - Andrews - 2003 - Journal of Neuroendocrinology - Wiley Online Library

Opioid Receptor Subtypes Involved in the Regulation of Prolactin Secretion  During Pregnancy and Lactation - Andrews - 2003 - Journal of  Neuroendocrinology - Wiley Online Library
Opioid Receptor Subtypes Involved in the Regulation of Prolactin Secretion During Pregnancy and Lactation - Andrews - 2003 - Journal of Neuroendocrinology - Wiley Online Library

Molecules | Free Full-Text | The Kappa Opioid Receptor Agonist 16-Bromo  Salvinorin A Has Anti-Cocaine Effects without Significant Effects on  Locomotion, Food Reward, Learning and Memory, or Anxiety and  Depressive-like Behaviors
Molecules | Free Full-Text | The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors

Opioid Receptor Subtypes Involved in the Regulation of Prolactin Secretion  During Pregnancy and Lactation - Andrews - 2003 - Journal of  Neuroendocrinology - Wiley Online Library
Opioid Receptor Subtypes Involved in the Regulation of Prolactin Secretion During Pregnancy and Lactation - Andrews - 2003 - Journal of Neuroendocrinology - Wiley Online Library

Characterization of Pyrrolidinyl-hexahydro-pyranopiperazines as a Novel  Kappa Opioid Receptor Agonist Scaffold | ACS Chemical Neuroscience
Characterization of Pyrrolidinyl-hexahydro-pyranopiperazines as a Novel Kappa Opioid Receptor Agonist Scaffold | ACS Chemical Neuroscience

Antagonists of the kappa opioid receptor. | Semantic Scholar
Antagonists of the kappa opioid receptor. | Semantic Scholar

Nalmefene Induced Elevation in Serum Prolactin in Normal Human Volunteers:  Partial Kappa Opioid Agonist Activity? | Neuropsychopharmacology
Nalmefene Induced Elevation in Serum Prolactin in Normal Human Volunteers: Partial Kappa Opioid Agonist Activity? | Neuropsychopharmacology

Advances in Sulfonamide Kappa Opioid Receptor Antagonists: Structural  Refinement and Evaluation of CNS Clearance | ACS Chemical Neuroscience
Advances in Sulfonamide Kappa Opioid Receptor Antagonists: Structural Refinement and Evaluation of CNS Clearance | ACS Chemical Neuroscience

Molecules | Free Full-Text | The Kappa Opioid Receptor Agonist 16-Bromo  Salvinorin A Has Anti-Cocaine Effects without Significant Effects on  Locomotion, Food Reward, Learning and Memory, or Anxiety and  Depressive-like Behaviors
Molecules | Free Full-Text | The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors